| CEA |  |
Anti-CEA is employed essentially as a tool to assist in the distinction between adenocarcinoma and malignant mesotheliomas of the epithelial type, along with other markers such as Calretinin, CK 5&6, Leu M1, HBME-1, MOC-31, and Ber-EP4. Another suggested use of CEA is to immunophenotype various metastatic adenocarcinomas as a means of identifying their origin. Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.
Mouse Monoclonal, Clone: CEA31| | 0.1 ml concentrated | 236M-94 | | | 0.5 ml concentrated | 236M-95 | | | 1 ml concentrated | 236M-96 | | | 1 ml prediluted | 236M-97 | | | 7 ml prediluted | 236M-98 | | | 5 Positive Control Slides | 236S | | |
|
Regulatory Status
|
Rabbit Polyclonal| | 0.1 ml concentrated | 236A-14 | | | 0.5 ml concentrated | 236A-15 | | | 1 ml concentrated | 236A-16 | | | 1 ml prediluted | 236A-17 | | | 7 ml prediluted | 236A-18 | | | 5 Positive Control Slides | 236S | | | |
|
